Skip to main content
An official website of the United States government
The SBIR and STTR programs were reauthorized on April 13, 2026. Currently, NIH has no active SBIR or STTR Notices of Funding Opportunity (NOFOs). Future NOFOs are forecasted at Grants.gov prior to opening for applications. The next standard receipt date is September 5, 2026.

Past Showcase Companies

Through NCI SBIR Investor Initiatives, SBIR- and STTR-funded companies have the opportunity to pitch their cancer technology innovations and receive feedback to help attract third-party investors and strategic partners. To learn more about the companies that have participated, explore our collection of Investor Initiatives company portfolio books on this page.

NCI SBIR is dedicated to full accessibility and the inclusion of individuals with disabilities. We continuously strive to improve the accessibility of our content, recognizing that some may be more accessible than others. If you encounter content on this page that does not meet your accessibility needs, please contact ncisbir@mail.nih.gov.

Email